Phase 4 Long COVID Trial, Recruiting NCT06441955 Sponsor: Well- Konnect Healthcare Services and Research Firm Condition: Long COVID
Back to Long Covid

Phase 4 Long COVID Trial, Recruiting

NCT06441955
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are at least 18 years old.
  • People who have had a confirmed or clinically diagnosed case of COVID-19.
  • People who have continued to experience symptoms after recovering from the initial illness.
  • People who are willing to give their consent to take part in the study.
  • People who can communicate in English, or who have access to a translator.
  • People who are able to attend follow-up appointments as required by the study.
  • People who do not have any medical conditions or take medications that could affect the study results (confirm with trial site).

Who may not be able to join:

  • People who are under 18 years of age (confirm with trial site, as this appears to overlap with the inclusion criteria).
  • People with a history of myocarditis (a condition involving inflammation of the heart muscle).
  • People with a history of pericarditis (a condition involving inflammation of the lining around the heart).
  • People with a history of severe kidney problems, specifically where kidney function is significantly reduced (known medically as eGFR below 30 mL/min — confirm with trial site if unsure about kidney function status).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Kawana J Williams, Ph.D., The National Institute of Health All of Us Research Program At Well-Konnect Healthcare Services and Research Center

Phone: 2406201587

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Well- Konnect Healthcare Services and Research Firm
Registry
ClinicalTrials.gov
Start date
1 March 2024
Est. completion
30 September 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Adherence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov